Hikma Launches Multiple Concentrations Of Clindamycin In The US
The Launch Follows a Flurry Of Updates Linked To Hikma
Executive Summary
After presenting its interim results for the past six months in August, Hikma has announced a further injectable launch in the US while also dealing with legal developments in the country.